SOD1 and Hyperglycemia: On the cellular level, we demonstrated a dose-dependent downregulation of cytokines, chemokines and NOX isoforms by hidrosmin in VSMC exposed to hyperglycemia, as well as SOD1 and catalase upregulation, thus confirming its anti-inflammatory and antioxidant action in the diabetes context.